New online program aims to support korean breast cancer patients
NCT ID NCT07499089
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test a culturally tailored online peer-support program for Korean-speaking breast cancer survivors and patients. Over 12 weeks, mentors (survivors) and mentees (patients in treatment) will interact through a bilingual platform. Researchers will measure whether the program is engaging and whether it improves quality of life, anxiety, depression, and social support.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
online peer-support program
What this could lead to
If successful, this could provide a culturally tailored support option to improve emotional well-being and social support for Korean breast cancer patients and survivors.
What could go wrong
This is a very small early-stage study (24 participants) focused on feasibility, so it may not show clear benefits or be generalizable to all Korean breast cancer survivors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars Siani Cancer
Los Angeles, California, 90048, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••